MDM2 and Osteoblastoma: Upon inclusion of osteoblastomas and osteosarcomas lacking MDM2 and/or CDK4 amplification, the tumours formed a spectrum when viewed according to TP53 mutational status (Fig. 6B; Supplementary Movie 1).